Strengths and considerations
No source-reviewed explanatory claims are recorded here yet.
Configuration
Original
Original as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label
Sources
Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2Overview
Key specifications have not been extracted for this record. See the linked evaluation and sources for the reported setup.
limited source coverage · Automated source review, 2026-09-17. All specifications and missing details
Evaluations and results
1 evaluation · 7 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.94 AUROC fraction · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUROC; XML row2 column8 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.008 Weighted F1 fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.008 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Weighted F1; XML row2 column5 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.78 ± 0.046 MCC dimensionless · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.046 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column MCC; XML row2 column6 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.84 ± 0.049 AUPRC fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.049 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column AUPRC; XML row2 column7 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.74 ± 0.071 Sensitivity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.071 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Sensitivity; XML row2 column3 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.96 ± 0.008 Val Accuracy fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.008 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2 |
| Configuration: Original | Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) Dataset: Protective-antigen classification feature comparison | 0.99 ± 0.004 Specificity fraction · higher Uncertainty: type: reported_plus_minus_type_unresolved; value: 0.004 Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceOriginal: Protective-antigen classification feature comparison Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples. Aggregation: Not reported Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Specificity; XML row2 column4 |
Source checking is not independent reproduction. Release 2026-09-29-06401fd5b220.
Use this model
How it works, versions and access
How it works
Evaluation in this paper
Paper-specific evaluated pipeline; exact checkpoint not inferred from label
Sources
Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Original, column Val Accuracy; XML row2 column2Strengths, limitations and unresolved questions
Strengths and limitations
Limitations and conditions
No source-reviewed explanatory claims are recorded here yet.
Profile review details
Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.
Stable record: paper-model-9b728492d4073915c4Specifications
Inputs, training, access and other details
Explanatory profile: limited source coverage · Automated source review, 2026-09-17. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.
| Property | Description and evidence |
|---|---|
| Model type | Not extracted or verified for this record. |
| Inputs | Not extracted or verified for this record. |
| Outputs | Not extracted or verified for this record. |
| Parameters | Not extracted or verified for this record. |
| Known versions | Not extracted or verified for this record. |
| Training data | Not extracted or verified for this record. |
| Context limits | Not extracted or verified for this record. |
| Access | Not extracted or verified for this record. |
| Code licence | Not extracted or verified for this record. |
| Weights licence | Not extracted or verified for this record. |
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
2 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Evaluation in this paper Paper-specific evaluated pipeline; exact checkpoint not inferred from label Individual claims | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1., row Original, column Val Accuracy; XML row2 column2 Version: preprint version in PMC | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
| Introduction Original as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label Individual claims | Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features Table 1., row Original, column Val Accuracy; XML row2 column2 Version: preprint version in PMC | source checked automated source review · 2026-09-17 Audit detailsPrimary-source transcription and separate automated review. No human sign-off or experimental reproduction. Field: Source artifact SHA-256: Hash scope: Exact retrieved primary paper artifact bytes. |
Sources and history
View linked audit checks and correction history
Release 2026-09-29-06401fd5b220 · Record review: needs review
1 source records and release history
- Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Original source · preprint version in PMC
Technical metadata and extraction receipts
Stable ID: paper-model-9b728492d4073915c4
- areas
- proteins-complexes
- tasks
- vaccine-antigen candidate prediction
- entity level
- method
- configuration type
- reported_configuration
- version
- Paper-specific evaluated pipeline; exact checkpoint not inferred from label
- legacy kinds
- model
- entity classification
- review date: 2026-09-17; rationale: This source-scoped entry preserves the method/configuration actually named in an evaluation. It is neither a global family identity nor proof of an immutable checkpoint; the linked evaluation retains adaptation, fitting and scoring details.; source ids: part2-vaxign-esm-2024; source locator: Table 1., row Original, column Val Accuracy; XML row2 column2; ambiguities: Configuration means the source-labelled evaluated identity. It does not establish missing checkpoint hashes, default settings or equivalence to same-named records in other papers.